Dr. Arvinder Singh CEO of Arth Diagnostics, Udaipur sharing his research in collaboration with HORIBA and Dr. Neeraj Jain.
Study shows that third-party reagents are inferior because they show bacterial and fungal contamination, leads to false flags and alarms and substandard patient CBC parameter reporting. Moreover, authenticity and traceability of manufacturer of third party is missing.
The study shows that although the cost of the third-party reagents is lesser than the original certified reagents of the company which leads to saving of money for the clinical laboratory but leads to compromise in quality of patient results as well as long term damage to instruments and increased maintenance cost.
We advise laboratory to use reagents of Original Equipment Manufacturer (OEM) to ensure better and consistent quality.
